Osteopontin Deficiency in Rat Vascular Smooth Muscle Cells is Associated with an Inability to Adhere to Collagen and Increased Apoptosis

Department of Pediatrics, The Mount Sinai School of Medicine, New York, New York 10029, USA.
Laboratory Investigation (Impact Factor: 3.83). 12/2000; 80(11):1603-15. DOI: 10.1038/labinvest.3780171
Source: PubMed

ABSTRACT Osteopontin (OPN) is an extracellular matrix protein that has been implicated in vascular smooth muscle cell (VSMC) adhesion. We have previously described the generation of OPN-deficient VSMC that displayed altered adhesion to collagen. We have examined further the causes and consequences of this altered adhesion. OPN-deficiency was associated with a significant reduction in surface expression of alpha1 and beta1 integrins (mean fluorescence intensity alpha1: OPN-deficient 0.135+/-0.04 vs. control 0.313+/-0.05, p < 0.0001; beta1: OPN-deficient 0.398+/-0.09 vs. control 0.570+/-0.05, p < 0.004). Treatment of normal VSMC with antibody to alpha1 recapitulated the adhesion defect. OPN-deficient cells without collagen exposure had an apoptotic fraction of 1.9%, which increased to 95.7% after 24 hours exposure to collagen. Exogenous OPN added to cultures within 15 minutes of plating restored normal cell adhesion, but did not prevent cells from undergoing apoptosis. Normal VSMC had no detectable apoptosis after 24 hours incubation in suspension, whereas OPN-deficient cells had an apoptotic fraction of 37.5% when incubated in suspension under the same conditions. The data suggest that OPN-deficient VSMC have two distinct abnormalities: an alpha1beta1-mediated inability to adhere normally to collagen and an increased propensity for apoptosis.

Download full-text


Available from: Andrea S Weintraub, Feb 09, 2015
  • Source
    • "Additionally, osteopontin-deficient vascular smooth muscle cells show increased apoptosis and decreased adherence. This not only provides further evidence for the role of osteopontin in cellular adherence but also in the inhibition of apoptosis (Weintraub et al, 2000). The mechanism by which osteopontin inhibits apoptosis is thought to be via multiple ligand receptor interactions in response to various proapoptotic signals (Denhardt et al, 2001). "
    [Show abstract] [Hide abstract]
    ABSTRACT: A metastatic phenotype can be induced in benign rat mammary cells (Rama 37 cells) by transfecting them with metastasis-inducing DNAs (Met-DNAs). Stable transfection of Met-DNAs increases the level of the metastasis-associated protein, osteopontin. Randomly picked clonal cell lines have been established from the pool of Rama 37 cells transfected with one metastasis-inducing DNA, C9-Met-DNA. In these cell lines, moderate correlation is observed between the copy number of C9-Met-DNA and their metastatic potential (linear regression coefficient, R(2)=0.48). A very close correlation is observed between the cell lines' metastatic potential in vivo and the osteopontin mRNA levels in vitro (R(2)=0.74), but not with another metastasis-associated protein in this system, S100A4 (R(2)=0.21). A close correlation is also observed between osteopontin mRNA levels and the adhesive potential (R(2)=0.91) of the cells, but not with their growth rate in vitro (R(2)=0.03). These observations support the previous suggestion that osteopontin is the direct effector of C9-Met-DNA and that the presence of C9-Met-DNA is necessary, if not sufficient, for the induction of metastasis in vivo in this system. Additionally, these results suggest that Rama 37 cells with increased osteopontin mRNA levels become metastatic not through an increased growth rate, but through an increase in cellular adhesiveness.
    British Journal of Cancer 06/2004; 90(9):1796-802. DOI:10.1038/sj.bjc.6601683 · 4.82 Impact Factor
  • Source
    QJM: monthly journal of the Association of Physicians 02/2002; 95(1):3-13. DOI:10.1093/qjmed/95.1.3 · 2.46 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The growth of melanocytes, the pigment-producing cells of the skin, normally is restricted to the epidermis. Transformed melanocytes, which have invaded the dermis, however, have gained the ability to grow in this new environment and to counteract apoptosis induced by the dermal connective tissue. The expression of genes contributing to the survival of melanocytes in the dermal environment, therefore, might be involved in melanoma development. Using a differential display approach, we identified osteopontin as such a gene. In melanocytes, expression of the secreted adhesion protein OPN was up-regulated by the melanoma-inducing receptor tyrosine kinase Xmrk as well as by the fibroblast growth factor receptor, which plays a decisive role in human melanoma. Activation of both receptors triggered survival of melanocytes in three-dimensional dermal collagen gels. Competition experiments revealed that the presence of OPN in the medium as a result of receptor signaling was contributing to these effects. Addition of exogenous OPN allowed melanocytes to adhere, spread, and survive in three-dimensional collagen gels, whereas in the absence of OPN, the cells underwent apoptosis. The integrin alpha(v)beta(3) known to be involved in melanoma cell survival and growth was identified as an OPN receptor, which points to an OPN-mediated cross-talk between growth factor receptors and this integrin receptor in melanocytes. In summary, we could show that in melanocytes growth factor receptor-induced secretion of OPN can promote antiapoptotic signaling and mediate appropriate interactions with the extracellular matrix in an autocrine way. Our findings suggest a new role of growth factor receptors of the family of receptor tyrosine kinases in processes associated with melanoma development and progression.
    Cancer Research 09/2002; 62(16):4820-8. · 9.28 Impact Factor
Show more